MALT lymphoma presenting as a meningioma.
Abboud
Halim
H
Carpentier
Antoine
A
Martin-Duverneuil
Nadine
N
Kujas
Michele
M
Hoang-Xuan
Khe
K
D018951:Antigens, CD20 / Q000378:metabolism; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000378:metabolism*; D001706:Biopsy; D003937:Diagnosis, Differential; D004359:Drug Therapy, Combination; D004388:Dura Mater / Q000473:pathology; D006801:Humans; D007150:Immunohistochemistry; D018442:Lymphoma, B-Cell, Marginal Zone / Q000175:diagnosis* / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology* / Q000601:surgery; D008279:Magnetic Resonance Imaging; D008297:Male; D008579:Meningioma / Q000175:diagnosis* / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology* / Q000601:surgery; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D009367:Neoplasm Staging; D011344:Procarbazine / Q000627:therapeutic use; D016896:Treatment Outcome
D018951:Antigens, CD20; D000964:Antimetabolites, Antineoplastic; D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; D011344:Procarbazine; D008727:Methotrexate